Assessing peripheral neuropathy

Thursday 18th February 2021

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous about mentioning peripheral neuropathy, and often minimise its impact, as they are concerned that their treatment could be reduced or stopped.

GatewayC’s Managing Physical Effects course reviews the common side effects of cancer treatments and aims to help in the identification and management of some specific short- and long-term side effects, including peripheral neuropathy. This course features an interactive video consultation which demonstrates how a GP might assess the seriousness of the peripheral neuropathy of a colorectal cancer patient.

Find out more:

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Cancer Keys: Brain Tumours and Headaches

Cancer Keys: Brain Tumours and Headaches

Whilst many people may associate brain tumours with headaches, often affected patients do not present with a headache until a later stage, if at all. Potential pitfall: Only up to 16% of brain tumour patients present to their GP with an isolated headache*; some...

read more

Related Posts